Pages that link to "Q34358030"
Jump to navigation
Jump to search
The following pages link to Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression (Q34358030):
Displaying 79 items.
- Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis (Q24646726) (← links)
- Does angiotensin-1 converting enzyme genotype influence motor or cognitive development after pre-term birth? (Q24800014) (← links)
- Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient population (Q26741140) (← links)
- Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease (Q26810028) (← links)
- A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases (Q26861984) (← links)
- Endothelin-converting enzymes and related metalloproteases in Alzheimer's disease (Q26862901) (← links)
- Primary progressive aphasia and the evolving neurology of the language network (Q27011657) (← links)
- Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden (Q28074728) (← links)
- Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory Study (Q30419458) (← links)
- Words and objects at the tip of the left temporal lobe in primary progressive aphasia (Q30443503) (← links)
- Memory is preserved in older adults taking AT1 receptor blockers (Q33604279) (← links)
- Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure (Q33783409) (← links)
- Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer's disease (Q33867559) (← links)
- Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? (Q34002989) (← links)
- The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial. (Q34286911) (← links)
- ACE variants and association with brain Aβ levels in Alzheimer's disease (Q34310258) (← links)
- L655,240, acting as a competitive BACE1 inhibitor, efficiently decreases β-amyloid peptide production in HEK293-APPswe cells (Q34355809) (← links)
- New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy (Q34368970) (← links)
- Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor (Q34449990) (← links)
- Angiotensin II potentiates zinc-induced cortical neuronal death by acting on angiotensin II type 2 receptor (Q34461965) (← links)
- Treatment of vascular risk factors in patients with a diagnosis of Alzheimer's disease: a systematic review (Q34484520) (← links)
- Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors (Q34520210) (← links)
- Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses (Q34831241) (← links)
- The evidence for treating hypertension in older people with dementia: a systematic review. (Q35033101) (← links)
- Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies (Q36019970) (← links)
- Angiotensin II revisited: new roles in inflammation, immunology and aging (Q36039299) (← links)
- The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration (Q36226873) (← links)
- Latest Advances on Interventions that May Prevent, Delay or Ameliorate Dementia (Q36443742) (← links)
- Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease (Q36551172) (← links)
- Cardiac risk factors and potential treatments in Alzheimer's disease (Q36582769) (← links)
- Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging (Q36670162) (← links)
- A multi-center study of ACE and the risk of late-onset Alzheimer's disease (Q36847601) (← links)
- An exploration of the potential mechanisms and translational potential of five medicinal plants for applications in Alzheimer's disease (Q36987635) (← links)
- Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia (Q36989228) (← links)
- Enalapril protects endothelial cells against induced apoptosis in Alzheimer's disease (Q37094983) (← links)
- Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme. (Q37107046) (← links)
- Brain renin angiotensin in disease (Q37127331) (← links)
- ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's disease (Q37139242) (← links)
- Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors (Q37600876) (← links)
- Aspects of beta-amyloid as a biomarker for Alzheimer's disease (Q37755129) (← links)
- Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? (Q37961852) (← links)
- Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases (Q38021079) (← links)
- Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade. (Q38066233) (← links)
- Renin-angiotensin-aldosterone system has a pivotal role in cognitive impairment (Q38108717) (← links)
- Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease (Q38116974) (← links)
- Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease (Q38306848) (← links)
- Antihypertensive Therapies and Cognitive Function: a Review (Q38571859) (← links)
- The renin-angiotensin system: a possible new target for depression (Q38651269) (← links)
- Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives (Q38690145) (← links)
- Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis (Q39034947) (← links)
- Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort (Q39356544) (← links)
- Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis (Q39379518) (← links)
- Inhibition of the renin-angiotensin system and the prevention of stroke (Q40234577) (← links)
- The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release (Q41858391) (← links)
- Comparative Effect of Lisinopril and Fosinopril in Mitigating Learning and Memory Deficit in Scopolamine-Induced Amnesic Rats. (Q41860101) (← links)
- Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse. (Q42069095) (← links)
- Angiotensin II-inhibiting drugs have no effect on intraneuronal Aβ or oligomeric Aβ levels in a triple transgenic mouse model of Alzheimer's disease. (Q42069122) (← links)
- Inhibition of ACE Retards Tau Hyperphosphorylation and Signs of Neuronal Degeneration in Aged Rats Subjected to Chronic Mild Stress (Q43132831) (← links)
- Association between an angiotensin-converting enzyme gene polymorphism and Alzheimer's disease in a Tunisian population (Q47140348) (← links)
- Angiotensin Converting Enzyme Inhibitors Ameliorate Brain Inflammation Associated with Microglial Activation: Possible Implications for Alzheimer's Disease (Q48550641) (← links)
- Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats. (Q48553675) (← links)
- Inhibition of the cerebral renin-angiotensin system to limit cognitive decline in elderly hypertensive persons (Q49030226) (← links)
- N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease (Q50101151) (← links)
- Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease (Q50516923) (← links)
- Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure. (Q50548806) (← links)
- Emotional therapy for patients with dementia. (Q50760646) (← links)
- Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study. (Q51813816) (← links)
- Effect of oral care on cognitive function in patients with dementia (Q51835743) (← links)
- Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: an observational study. (Q51893818) (← links)
- The use of angiotensin-converting enzyme inhibitors and diuretics is associated with a reduced incidence of impairment on cognition in elderly women. (Q51894479) (← links)
- The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment? (Q52347539) (← links)
- The Nicotianamine Synthase Gene Is a Useful Candidate for Improving the Nutritional Qualities and Fe-Deficiency Tolerance of Various Crops. (Q55274436) (← links)
- Nanoparticles for the Treatment of Alzheimer's Disease: Theoretical Rationale, Present Status and Future Perspectives (Q57341564) (← links)
- Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy (Q58477361) (← links)
- Computational Studies Applied to Flavonoids against Alzheimer's and Parkinson's Diseases (Q61453872) (← links)
- Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition (Q80768190) (← links)
- Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer's patients (Q90337785) (← links)
- Influenza A virus mimetic nanoparticles trigger selective cell uptake (Q91622704) (← links)
- The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) (Q92377672) (← links)